Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
tSz2dQrr0yRp1rgC